| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |